JPMORGAN CHASE & CO - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$26,511
+758.5%
20,875
+120.4%
0.00%
Q2 2023$3,088
+54.4%
9,472
+153.3%
0.00%
Q1 2023$2,0003,739
+630.3%
0.00%
Q4 2022$0512
+739.3%
0.00%
Q3 2022$0610.0%0.00%
Q2 2022$0610.0%0.00%
Q1 2022$0610.0%0.00%
Q4 2021$0610.0%0.00%
Q3 2021$0
-100.0%
61
-100.0%
0.00%
Q2 2021$1,121,000
+37.5%
212,005
+20.8%
0.00%
Q1 2021$815,000
+7.9%
175,432
-23.4%
0.00%
Q4 2020$755,000
+7.7%
229,001
+8.0%
0.00%
Q3 2020$701,000
-26.2%
212,082
-24.7%
0.00%
Q2 2020$950,000
-13.0%
281,702
-1.2%
0.00%
Q1 2020$1,092,000
-45.6%
285,245
-14.2%
0.00%
Q4 2019$2,008,000
-28.2%
332,484
-10.1%
0.00%
-100.0%
Q3 2019$2,796,000
+49.9%
369,839
+152.0%
0.00%
Q2 2019$1,865,000
+336.8%
146,767
+2.2%
0.00%
Q4 2018$427,000
+302.8%
143,608
+1075.5%
0.00%
Q1 2018$106,000
+231.2%
12,217
+385.6%
0.00%
Q4 2017$32,000
+540.0%
2,516
+403.2%
0.00%
Q3 2017$5,000
-99.9%
500
-99.8%
0.00%
-100.0%
Q2 2017$5,539,000
+55290.0%
326,450
+65190.0%
0.00%
Q1 2017$10,000
-99.4%
500
-99.7%
0.00%
Q1 2016$1,653,000
-8.8%
174,900
-2.8%
0.00%
Q4 2015$1,813,000180,0000.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 3,662,342$7,874,0000.16%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 213,469$438,0000.07%
GSA CAPITAL PARTNERS LLP 150,914$309,0000.04%
Bernardo Wealth Planning LLC 30,469$62,0000.03%
Penserra Capital Management LLC 351,154$719,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,900$361,0000.01%
Founders Capital Management 3,000$9,0000.01%
King Wealth Management Group 16,000$33,0000.01%
Aquatic Capital Management LLC 1,900$4,0000.01%
Newbridge Financial Services Group, Inc. 6,075$12,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders